slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 25,771-25,800
Pages 1,371
Rows per page 30
Component
25,771-25,800 of 41,127
05
AChR-Ab+ population; data includes patient counts per cycle/week.argenx SE | Results Presentation Deck | 10 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
07
The table displays IR/PY (Incidence Rate per Patient Year) and % (n) for various safety categories.argenx SE | Results Presentation Deck | 10 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a waterfall chart to bridge the gap between inflationary pressures and cost mitigation.Asos | Results Presentation Deck | 35 slides · Asos
Conference presentation Investor relations Loop · Domino Effect1 hit
35
Asos | Results Presentation Deck | 35 slidesAsos | Results Presentation Deck | 35 slides · Asos
Conference presentation Investor relations 1 hit
02
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
10
The slide highlights operating leverage by comparing revenue growth (60%) to operating profit growth (60%) and EPS growth (20%).AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
12
The waterfall chart illustrates the bridge between two net debt figures.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
Includes ASCO 2022 conference branding and clinical trial abbreviations.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
Includes detailed trial design diagrams for EMERALD-3 and SAFFRON studies.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
19
Includes footnotes regarding reporting changes and definitions of acronyms.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
20
Includes detailed footnotes regarding pro-forma growth calculations and definitions of acronyms.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
21
Includes clinical trial charts for AZD8233 and eplontersen, alongside a list of regulatory milestones.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
The slide uses a split layout: left side details R&D strategy (LCM vs NME), right side provides a timeline of upcoming regulatory/clinical milestones.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
The slide uses a matrix structure where rows are event types and columns are time periods.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
38
The data reflects revenue post-acquisition of Alexion by AstraZeneca starting Q3 2021.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
39
The slide uses a three-column layout to categorize ESG metrics, with footnotes providing detailed methodology and scope definitions.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
40
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
63
The chart uses a waterfall-bridge structure to show margin expansion drivers.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations Beat · Satisfaction1 hit
02
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
04
The slide uses a standard pharmaceutical pipeline table format.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
06
Uses a biological mechanism diagram to contrast normal vs. disease states and the therapeutic intervention.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
10
Includes fMRI and behavioral task data from a 4-way crossover study.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
11
The slide uses a flywheel diagram to illustrate the benefits of BNC210 and a comparison table to validate the competitive advantage.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
12
Includes a pharmacokinetic chart showing concentration vs time for different doses.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · Why Now1 hit
16
The slide uses a before-after-bridge style structure to connect the problem (anxiety/PTSD) to the solution (BNC210) via experimental evidence.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
21
The slide highlights a specific partnership with Merck, detailing financial milestones and clinical progress, supported by bar charts showing efficacy in animal models.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
04
Includes a disclaimer regarding GAAP reconciliation and definition updates for 2022.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
09
Includes detailed footnotes regarding adjustments to GAAP figures.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
11
Includes a detailed footnote regarding methodology changes in Q1 2022.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
12
BlackRock | Results Presentation Deck | 12 slidesBlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit